Azitra joins a relatively small group of biotechs seeking an IPO in the past few quarters, with only a handful going public in recent memory, including two on back-to-back Fridays this month.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,